Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer

We conducted a phase I study of a weekly nab-paclitaxel and S-1 combination therapy in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer. The primary objective was to estimate the maximum tolerated and recommended doses. Each treatment was repeated every 2...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Sci
Main Authors: Tsurutani, Junji, Kuroi, Katsumasa, Iwasa, Tsutomu, Miyazaki, Masaki, Nishina, Shinichi, Makimura, Chihiro, Tanizaki, Junko, Okamoto, Kunio, Yamashita, Toshinari, Aruga, Tomoyuki, Shigekawa, Takashi, Komoike, Yoshifumi, Saeki, Toshiaki, Nakagawa, Kazuhiko
Format: Artigo
Jezik:Inglês
Izdano: BlackWell Publishing Ltd 2015
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4471786/
https://ncbi.nlm.nih.gov/pubmed/25786335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12658
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki